Form 4: Thermo Fisher Scientific CEO Marc Casper Executes Stock Options and Sells Shares Under 10b5-1 Plan

Thermo Fisher Scientific's CEO, Marc Casper, exercised stock options and sold shares of common stock on October 28 and 29, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Marc N. Casper, the Chairman and CEO of Thermo Fisher Scientific, executed stock options and sold shares of the company's common stock on October 28 and 29, 2024.
• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 10, 2023.
• On both October 28 and 29, Casper exercised options to purchase 10,000 shares at a price of $210.68 per share.
• Concurrently, Casper sold shares in multiple transactions at varying prices, ranging from $547.755 to $558.79.
• The total number of shares sold on October 28 was 9,995 and on October 29 was 9,900.
• Following these transactions, Casper directly owns 121,191.54 shares of Thermo Fisher Scientific common stock.
• Casper also indirectly owns shares through the Alison Casper 2020 Irrevocable Trust (11,300 shares), Floral Park Associates, Inc. (43,608 shares), and the MNC 2020 Irrevocable Trust (5,000 shares).

Sentiment

Score: 5

Explanation: The document reflects routine transactions under a pre-arranged trading plan, indicating a neutral sentiment.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Rule 10b5-1 plans allow insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information. These transactions are closely watched by investors for insights into management's perspective on the company's value.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
• The use of Rule 10b5-1 trading plans is a standard practice among corporate executives to manage their stock holdings while avoiding accusations of insider trading.
• Comparable companies such as Danaher, Agilent, and PerkinElmer also see regular Form 4 filings from their executives related to stock option exercises and sales.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased supply of shares in the market.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates